Individually Adaptive Artificial Pancreas in Subjects with Type 1 Diabetes: A One-Month Proof-of-Concept Trial in Free-Living Conditions-Reference-Cited by-同舟云学术

Individually Adaptive Artificial Pancreas in Subjects with Type 1 Diabetes: A One-Month Proof-of-Concept Trial in Free-Living Conditions

Published:2017-10 Issue:10 Volume:19 Page:560-571
ISSN:1520-9156
Container-title:Diabetes Technology & Therapeutics
language:en
Short-container-title:Diabetes Technology & Therapeutics

Author:

Messori Mirko¹,Kropff Jort²,Del Favero Simone³,Place Jerome⁴,Visentin Roberto³,Calore Roberta³,Toffanin Chiara¹,Di Palma Federico¹,Lanzola Giordano⁵,Farret Anne⁴,Boscari Federico⁶,Galasso Silvia⁶,Avogaro Angelo⁶,Keith-Hynes Patrick⁷,Kovatchev Boris P.⁸,Bruttomesso Daniela⁶,Magni Lalo¹,DeVries J. Hans²,Renard Eric⁴,Cobelli Claudio³,for the AP@home consortium

Affiliation:

1. Department of Civil Engineering and Architecture, University of Pavia, Pavia, Italy.

2. Department of Endocrinology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

3. Department of Information Engineering, University of Padova, Padova, Italy.

4. Department of Endocrinology, Diabetes, Nutrition, Institute of Functional Genomics, CNRS UMR 5203, INSERM U1191, Montpellier University Hospital, INSERM Clinical Investigation Centre 1411, University of Montpellier, Montpellier, France.

5. Department of Electrical, Computer and Biomedical Engineering, University of Pavia, Pavia, Italy.

6. Unit of Metabolic Diseases, Department of Internal Medicine (DIM), University of Padova, Padova, Italy.

7. TypeZero Technologies, Charlottesville, Virginia.

8. Center for Diabetes Technology, University of Virginia, Charlottesville, Virginia.

Publisher

Mary Ann Liebert Inc

Subject

Medical Laboratory Technology,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://www.liebertpub.com/doi/pdf/10.1089/dia.2016.0463

Reference29 articles.

1. The Artificial Pancreas in 2016: A Digital Treatment Ecosystem for Diabetes

2. Coming of age: the artificial pancreas for type 1 diabetes

3. A run-to-run control strategy to adjust basal insulin infusion rates in type 1 diabetes

4. Run-to-Run Tuning of Model Predictive Control for Type 1 Diabetes Subjects: In Silico Trial

5. Automatic adaptation of basal therapy for Type 1 diabetic patients: a Run-to-Run approach

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pulsatile Zone MPC with asymmetric stationary cost for artificial pancreas based on a non-standard IOB constraint;Journal of Process Control;2024-04

2. Advanced decision support system for individuals with diabetes on multiple daily injections therapy using reinforcement learning and nearest-neighbors: In-silico and clinical results;Artificial Intelligence in Medicine;2024-02

3. Postprandial glucose‐management strategies in type 1 diabetes: Current approaches and prospects with precision medicine and artificial intelligence;Diabetes, Obesity and Metabolism;2024-01-23

4. Controlling Human Physiology via Drugs and Devices;Reference Module in Materials Science and Materials Engineering;2024

5. Performance Effect of Adjusting Insulin Sensitivity for Model-Based Automated Insulin Delivery Systems;Journal of Diabetes Science and Technology;2023-10-20